Radiation oncology in brain tumors: Current approaches and clinical trials in progress

Neuroimaging Clinics of North America

Volumn 20, Issue 3, 2010, Pages 401-408

  Chan, Michael D ^a   Tatter, Stephen B ^a   Lesser, Glenn ^a   Shaw, Edward G ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

CNS lymphoma; Glioblastoma; Glioma; Meningioma

Indexed keywords

BEVACIZUMAB; CARMUSTINE; CILENGITIDE; CYTARABINE; IRINOTECAN; LOMUSTINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PROCARBAZINE; RITUXIMAB; TEMOZOLOMIDE; TENIPOSIDE; VINCRISTINE;

BRAIN CANCER; BRAIN EDEMA; BRAIN RADIATION; CANCER GRADING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; GLIOBLASTOMA; GLIOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPHOMA; MENINGIOMA; MULTIPLE CYCLE TREATMENT; NEUROSURGERY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIOSURGERY; REVIEW;

ADULT; BRAIN NEOPLASMS; GLIOBLASTOMA; GLIOMA; HUMANS; LYMPHOMA; MENINGIOMA; RADIATION ONCOLOGY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77955568959     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2010.04.005     Document Type: Review

References (35)

1. Walker M.D., Strike T.A., Sheline G.E. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979, 5:1725-1731.
2. Walker M.D., Green S.B., Byar D.P., et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980, 303:1323-1329.
3. Kristiansen K., Hagen S., Kollevold T., et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 1981, 47:649-652.
4. Shapiro W.R., Green S.B., Burger P.C., et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 1989, 71:1-9.
5. Garden A.S., Maor M.H., Yung W.K., et al. Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol 1991, 20:99-110.
6. Halperin E.C., Bentel G., Heinz E.R., et al. Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys 1989, 17:1347-1350.
7. Coughlin C., Scott C., Langer C., et al. Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or equals 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients. Int J Radiat Oncol Biol Phys 2000, 48:1351-1358.
8. Deutsch M., Green S.B., Strike T.A., et al. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 1989, 16:1389-1396.
9. Werner-Wasik M., Scott C.B., Nelson D.F., et al. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. Cancer 1996, 77:1535-1543.
10. Nelson D.F., Diener-West M., Horton J., et al. Combined modality approach to treatment of malignant gliomas-re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Monogr 1988, 6:279-284.
11. Fitzek M.M., Thornton A.F., Harsh G.T., et al. Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial. Int J Radiat Oncol Biol Phys 2001, 51:131-137.
12. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996.
13. Wallner K.E., Galicich J.H., Krol G., et al. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989, 16:1405-1409.
14. Hess C.F., Schaaf J.C., Kortmann R.D., et al. Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 1994, 30:146-149.
15. Grosu A.L., Weber W.A., Riedel E., et al. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63:64-74.
16. Pirzkall A., McKnight T.R., Graves E.E., et al. MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 2001, 50:915-928.
17. Gonzalez J., Kumar A.J., Conrad C.A., et al. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 2007, 67:323-326.
18. Torcuator R., Zuniga R., Mohan Y.S., et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 2009, 94(1):63-68.
19. Vredenburgh J.J., Desjardins A., Herndon J.E., et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 2007, 25:4722-4729.
20. Reardon D.A., Nabors L.B., Stupp R., et al. Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme. Expert Opin Investig Drugs 2008, 17:1225-1235.
21. van den Bent M.J., Afra D., de Witte O., et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 2005, 366:985-990.
22. Karim A.B., Maat B., Hatlevoll R., et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996, 36:549-556.
23. Shaw E., Arusell R., Scheithauer B., et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 2002, 20:2267-2276.
24. Pignatti F., van den Bent M., Curran D., et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002, 20:2076-2084.
25. Keles G.E., Lamborn K.R., Berger M.S. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 2001, 95:735-745.
26. Nelson D.F., Martz K.L., Bonner H., et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992, 23:9-17.
27. DeAngelis L.M., Seiferheld W., Schold S.C., et al. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 2002, 20:4643-4648.
28. Abrey L.E., Yahalom J., DeAngelis L.M. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000, 18:3144-3150.
29. Poortmans P.M., Kluin-Nelemans H.C., Haaxma-Reiche H., et al. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. J Clin Oncol 2003, 21:4483-4488.
30. Batchelor T., Carson K., O'Neill A., et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol 2003, 21:1044-1049.
31. Shah G.D., Yahalom J., Correa D.D., et al. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 2007, 25:4730-4735.
32. Gavrilovic I.T., Hormigo A., Yahalom J., et al. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol 2006, 24:4570-4574.
33. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957, 20:22-39.
34. Pollock B.E., Stafford S.L., Utter A., et al. Stereotactic radiosurgery provides equivalent tumor control to Simpson grade 1 resection for patients with small- to medium-size meningiomas. Int J Radiat Oncol Biol Phys 2003, 55:1000-1005.
35. Kondziolka D., Mathieu D., Lunsford L.D., et al. Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery 2008, 62:53-58. [discussion: 58-60].